Pursuing paradoxical proconvulsant prophylaxis for epileptogenesis

Epilepsia

Volumn 50, Issue 7, 2009, Pages 1657-1669

  Armstrong, Caren ^a   Morgan, Robert J ^a   Soltesz, Ivan ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cannabinoid type 1; Endocannabinoids; Epilepsy; Epileptogenesis; SR141716A

Indexed keywords

2 ARACHIDONOYLGLYCEROL; CANNABINOID; CANNABINOID 1 RECEPTOR AGONIST; CANNABINOID 1 RECEPTOR ANTAGONIST; DRONABINOL; RIMONABANT; ANTICONVULSIVE AGENT; CONVULSANT AGENT; NEUROPROTECTIVE AGENT;

CENTRAL NERVOUS SYSTEM; CEREBROVASCULAR ACCIDENT; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG STRUCTURE; EPILEPSY; EPILEPTOGENESIS; MEDICAL RESEARCH; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SEIZURE; AGONISTS; ANIMAL; BRAIN; BRAIN DISEASE; COMPLICATION; DISEASE MODEL; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; PROCEDURES;

ANIMALS; ANTICONVULSANTS; BRAIN; BRAIN DISEASES; CANNABINOIDS; CONVULSANTS; DISEASE MODELS, ANIMAL; DRUG DELIVERY SYSTEMS; EPILEPSY; HUMANS; NEUROPROTECTIVE AGENTS;

EID: 67649939184     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/j.1528-1167.2009.02173.x     Document Type: Review

References (106)

1. Alger BE 2004) Endocannabinoids and their implications for epilepsy. Epilepsy Curr 4 : 169 173.
2. Annegers JF, Rocca WA, Hauser WA 1996) Causes of epilepsy: contributions of the Rochester epidemiology project. Mayo Clin Proc 71 : 570 575.
3. Appleton RE, Demellweek C 2002) Post-traumatic epilepsy in children requiring inpatient rehabilitation following head injury. J Neurol Neurosurg Psychiatry 72 : 669 672. (Pubitemid 34462830)
4. Arnone M, Maruani J, Chaperon F, Thiebot MH, Poncelet M, Soubrie P, Le Fur G 1997) Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors. Psychopharmacology (Berl) 132 : 104 106.
5. Baram TZ, Gerth A, Schultz L 1997) Febrile seizures: an appropriate-aged model suitable for long-term studies. Brain Res Dev Brain Res 98 : 265 270. (Pubitemid 27075283)
6. Barlow KM, Spowart JJ, Minns RA 2000) Early posttraumatic seizures in non-accidental head injury: relation to outcome. Dev Med Child Neurol 42 : 591 594.
7. Ben-Ari Y, Holmes GL 2008) Relevance of basic research to clinical data: Good answers, wrong questions!. Epilepsy Curr 8 : 19 22.
8. Bernard C, Milh M, Morozov YM, Ben-Ari Y, Freund TF, Gozlan H 2005) Altering cannabinoid signaling during development disrupts neuronal activity. Proc Natl Acad Sci U S A 102 : 9388 9393. (Pubitemid 40923573)
9. Bhaskaran MD, Smith BN (2007) Cannabinoid and vanilloid interactions in the dentate gyrus of a mouse model of temporal lobe epilepsy. Program no. 257.20/P7. 2007 Neuroscience Meeting Planner. San Diego, CA: Online.
10. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N, Freund TF 2005) Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25 : 6845 6856. (Pubitemid 41023152)
11. Chen K, Baram TZ, Soltesz I 1999) Febrile seizures in the developing brain result in persistent modification of neuronal excitability in limbic circuits. Nat Med 5 : 888 894. (Pubitemid 29372414)
12. Chen K, Ratzliff A, Hilgenberg L, Gulyas A, Freund TF, Smith M, Dinh TP, Piomelli D, Mackie K, Soltesz I 2003) Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39 : 599 611. (Pubitemid 36993578)
13. Chen K, Neu A, Howard AL, Foldy C, Echegoyen J, Hilgenberg L, Smith M, Mackie K, Soltesz I 2007) Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci 27 : 46 58. (Pubitemid 46089958)
14. Chevaleyre V, Castillo PE 2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38 : 461 472. (Pubitemid 36579147)
15. Compton D, Aceto M, Lowe J, Martin B 1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of delta 9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exp Ther 277 : 586 594. (Pubitemid 27168965)
16. Consroe PF, Wood GC, Buchsbaum H 1975) Anticonvulsant nature of marihuana smoking. JAMA 234 : 306 307.
17. Consroe P 1998) Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol Dis 5 : 534 551. (Pubitemid 29075849)
18. D'Ambrosio R, Fairbanks JP, Fender JS, Born DE, Doyle DL, Miller JW 2004) Post-traumatic epilepsy following fluid percussion injury in the rat. Brain 127 : 304 314. (Pubitemid 38160315)
19. Deshpande LS, Blair RE, Ziobro JM, Sombati S, Martin BR, DeLorenzo RJ 2007a) Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur J Pharmacol 558 : 52 59. (Pubitemid 46328867)
20. Deshpande LS, Sombati S, Blair RE, Carter DS, Martin BR, DeLorenzo RJ 2007b) Cannabinoid CB1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci Lett 411 : 11 16. (Pubitemid 44751939)
21. Despres JP, Golay A, Sjostrom L 2005) Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 353 : 2121 2134. (Pubitemid 41653104)
22. Devane W, Hanus L, Breuer A, Pertwee R, Stevenson L, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R 1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258 : 1946 1949. (Pubitemid 23026736)
23. Dichter MA 2009) Posttraumatic epilepsy: The challenge of translating discoveries in the laboratory to pathways to a cure. Epilepsia 50 (suppl 2 41 45.
24. Dube C, Chen K, Eghbal-Ahmadi M, Brunson K, Soltesz I, Baram TZ 2000) Prolonged febrile seizures in the immature rat model enhance hippocampal excitability long term. Ann Neurol 47 : 336 344. (Pubitemid 30141843)
25. Dube C, Richichi C, Bender RA, Chung G, Litt B, Baram TZ 2006) Temporal lobe epilepsy after experimental prolonged febrile seizures: prospective analysis. Brain 129 : 911 922.
26. Dudek FE, Bertram EH, Staley KJ 2008) Antiepileptogenesis therapy with levetiracetam: data from kindling versus status epilepticus models. Epilepsy Curr 8 : 28 30.
27. Echegoyen J, Armstrong C, Morgan RJ, Soltesz I 2009) Single application of a CB1 receptor antagonist rapidly following head injury prevents long-term hyperexcitability in a rat model. Epilepsy Res 85 : 123 127.
28. Ellison JM, Gelwan E, Ogletree J 1990) Complex partial seizure symptoms affected by marijuana abuse. J Clin Psychiatry 51 : 439 440. (Pubitemid 20359861)
29. Falenski KW, Blair RE, Sim-Selley LJ, Martin BR, DeLorenzo RJ 2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146 : 1232 1244. (Pubitemid 46694119)
30. Fernandez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M 2007) Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 28 : 39 45. (Pubitemid 46038536)
31. Foldy C, Neu A, Jones MV, Soltesz I 2006) Presynaptic, activity-dependent modulation of cannabinoid type 1 receptor-mediated inhibition of GABA release. J Neurosci 26 : 1465 1469. (Pubitemid 43237017)
32. Freund TF, Katona I, Piomelli D 2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83 : 1017 1066. (Pubitemid 36828930)
33. Friedman H, Klein TW, Newton C, Daaka Y 1995) Marijuana, receptors and immunomodulation. Adv Exp Med Biol 373 : 103 113.
34. Gaoni Y, Mechoulam R 1964) Isolation, structure, and partial synthesis of an active constituent of hashish. J Am Chem Soc 86 : 1646 1647.
35. Glickfeld LL, Scanziani M 2006) Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9 : 807 815.
36. Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, Uhl GR 2006) Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 1071 : 10 23. (Pubitemid 43255471)
37. Gordon E, Devinsky O 2001) Alcohol and marijuana: effects on epilepsy and use by patients with epilepsy. Epilepsia 42 : 1266 1272. (Pubitemid 33070666)
38. Gowers WR 1881) Epilepsy and other chronic convulsive diseases: their causes, symptoms and. treatment. J. & A Churchill, New Burlington St., London.
39. Hajos N, Katona I, Naiem SS, MacKie K, Ledent C, Mody I, Freund TF 2000) Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 12 : 3239 3249. (Pubitemid 30751104)
40. Hansen HH, Ikonomidou C, Bittigau P, Hansen SH, Hansen HS 2001a) Accumulation of the anandamide precursor and other N-acylethanolamine phospholipids in infant rat models of in vivo necrotic and apoptotic neuronal death. J Neurochem 76 : 39 46. (Pubitemid 32044366)
41. Hansen HH, Schmid PC, Bittigau P, Lastres-Becker I, Berrendero F, Manzanares J, Ikonomidou C, Schmid HH, Fernandez-Ruiz JJ, Hansen HS 2001b) Anandamide, but not 2-arachidonoylglycerol, accumulates during in vivo neurodegeneration. J Neurochem 78 : 1415 1427. (Pubitemid 32899773)
42. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, Rice KC 1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87 : 1932 1936.
43. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC 1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11 : 563 583.
44. Herman ST 2002) Epilepsy after brain insult: targeting epileptogenesis. Neurology 59 : S21 S26.
45. Howard AL, Neu A, Morgan RJ, Echegoyen JC, Soltesz I 2007) Opposing modifications in intrinsic currents and synaptic inputs in post-traumatic mossy cells: evidence for single-cell homeostasis in a hyperexcitable network. J Neurophysiol 97 : 2394 2409. (Pubitemid 46411169)
46. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M 2009) Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89 : 309 380.
47. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, Freund TF 1999) Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19 : 4544 4558. (Pubitemid 29241104)
48. Katona I, Sperlagh B, Magloczky Z, Santha E, Kofalvi A, Czirjak S, Mackie K, Vizi ES, Freund TF 2000) GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus. Neuroscience 100 : 797 804. (Pubitemid 30742283)
49. Katona I, Freund TF 2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nature Medicine 14 : 923 930.
50. Keeler MH, Reifler CB 1967) Grand mal convulsions subsequent to marijuana use. Case report. Dis Nerv Syst 28 : 474 475.
51. Kharatishvili I, Nissinen JP, McIntosh TK, Pitkänen A 2006) A model of posttraumatic epilepsy induced by lateral fluid-percussion brain injury in rats. Neuroscience 140 : 685 697.
52. Kharatishvili I, Immonen R, Grohn O, Pitkänen A 2007) Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis. Brain 130 : 3155 3168. (Pubitemid 350209080)
53. Klein TW 2005) Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 5 : 400 411. (Pubitemid 40685989)
54. Lange JHM, Kruse CG 2008) Cannabinoid CB1 receptor antagonists in therapeutic and structural perspectives. Chem Rec 8 : 156 168.
55. Leker RR, Gai N, Mechoulam R, Ovadia H 2003) Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210 Stroke 34 : 2000 2006. (Pubitemid 36944797)
56. Lichtman AH 2000) SR 141716A enhances spatial memory as assessed in a radial-arm maze task in rats. Eur J Pharmacol 404 : 175 179.
57. Losonczy A, Somogyi P, Nusser Z 2003) Reduction of excitatory postsynaptic responses by persistently active metabotropic glutamate receptors in the hippocampus. J Neurophysiol 89 : 1910 1919. (Pubitemid 36444247)
58. Lovinger DM 2007) Endocannabinoid liberation from neurons in transsynaptic signaling. J Mol Neurosci 33 : 87 93. (Pubitemid 47574963)
59. Lovinger DM 2008) Presynaptic modulation by endocannabinoids. Handb Exp Pharmacol 184 : 435 477.
60. Ludanyi A, Eross L, Czirjak S, Vajda J, Halasz P, Watanabe M, Palkovits M, Magloczky Z, Freund TF, Katona I 2008) Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 28 : 2976 2990.
61. Lutz B 2004) On-demand activation of the endocannabinoid system in the control of neuronal excitability and epileptiform seizures. Biochem Pharmacol 68 : 1691 1698. (Pubitemid 39278491)
62. Lutz B, Monory K 2008) Soothing the seizures of children. Nat Med 14 : 721 722.
63. Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M 2001) Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 31 : 463 475. (Pubitemid 32778564)
64. Marsicano G, Goodenough S, Monory K, Hermann H, Eder M, Cannich A, Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, Lopez-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B 2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 : 84 88. (Pubitemid 37210691)
65. Marson A, Jacoby A, Johnson A, Kim L, Gamble C, Chadwick D 2005) Immediate versus deferred antiepileptic drug treatment for early epilepsy and single seizures: a randomised controlled trial. Lancet 365 : 2007 2013. (Pubitemid 40805008)
66. Mato S, Chevaleyre V, Robbe D, Pazos A, Castillo PE, Manzoni OJ 2004) A single in-vivo exposure to delta 9THC blocks endocannabinoid-mediated synaptic plasticity. Nat Neurosci 7 : 585 586. (Pubitemid 38691895)
67. McIntosh AM, Berkovic SF 2005) Treatment of new-onset epilepsy: seizures beget discussion. Lancet 365 : 1985 1986. (Pubitemid 40804996)
68. Mechoulam R 1986) The pharmacohistory of Cannabis sativa. In Mechoulam R (Ed) Cannabinoids as therapeutic agents. Book CRC Press Inc., Boca Raton, Florida; USA, pp. 1 19.
69. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR, Pertwee RG, Griffin G, Bayewitch M, Barg J, Vogel Z 1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50 : 83 90.
70. Mechoulam R, Spatz M, Shohami E 2002) Endocannabinoids and neuroprotection. Sci STKE 2002 : RE5.
71. Mechoulam R, Lichtman AH 2003) Neuroscience. Stout guards of the central nervous system. Science 302 : 65 67.
72. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wolfel B, Dodt HU, Zieglgansberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G, Lutz B 2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51 : 455 466. (Pubitemid 44209321)
73. Murray RM, Morrison PD, Henquet C, Di Forti M 2007) Cannabis, the mind and society: the hash realities. Nat Rev Neurosci 8 : 885 895. (Pubitemid 350006219)
74. Navarro M, Hernandez E, Munoz RM, del Arco I, Villanua MA, Carrera MR, Rodriguez de Fonseca F 1997) Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat. Neuroreport 8 : 491 496.
75. Neu A, Foldy C, Soltesz I 2007) Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578 : 233 247. (Pubitemid 44971121)
76. Ng SKC, Brust JCM, Hauser WA, Susser M 1990) Illicit drug use and the risk of new onset seizures. Am J Epidemiol 132 : 47 57. (Pubitemid 20203302)
77. Nissinen J, Large CH, Stratton SC, Pitkänen A 2004) Effect of lamotrigine treatment on epileptogenesis: an experimental study in rat. Epilepsy Res 58 : 119 132. (Pubitemid 38553948)
78. Ohno-Shosaku T, Matsui M, Fukudome Y, Shosaku J, Tsubokawa H, Taketo MM, Manabe T, Kano M 2003) Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus. Eur J Neurosci 18 : 109 116. (Pubitemid 36920851)
79. Pacher P, Batkai S, Kunos G 2006) The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 58 : 389 462. (Pubitemid 44394908)
80. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, Shohami E 2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413 : 527 531. (Pubitemid 32938751)
81. Pertwee RG 2005) The therapeutic potential of drugs that target cannabinoid receptors or modulate the tissue levels or actions of endocannabinoids. Aaps J 7 : E625 E654.
82. Pertwee RG 2007) GPR55: a new member of the cannabinoid receptor clan? Br J Pharmacol 152 : 984 986. (Pubitemid 350166047)
83. Piomelli D 2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4 : 873 884. (Pubitemid 37351427)
84. Piomelli D, Astarita G, Rapaka R 2007) A neuroscientist's guide to lipidomics. Nat Rev Neurosci 8 : 743 754. (Pubitemid 47462119)
85. Pi-Sunyer FX, AronneL J, Heshmati HM, Devin J, Rosenstock J 2006) Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295 : 761 775. (Pubitemid 43244304)
86. Pitkänen A, Narkilahti S, Bezvenyuk Z, Haapalinna A, Nissinen J 2004) Atipamezole, an alpha(2)-adrenoceptor antagonist, has disease modifying effects on epileptogenesis in rats. Epilepsy Res 61 : 119 140. (Pubitemid 39296704)
87. Pitkänen A, Kharatishvili I, Karhunen H, Lukasiuk K, Immonen R, Nairismagi J, Grohn O, Nissinen J 2007) Epileptogenesis in experimental models. Epilepsia 48 (suppl 2 13 20. (Pubitemid 46849999)
88. Pitler TA, Alger BE 1994) Depolarization-induced suppression of GABAergic inhibition in rat hippocampal pyramidal cells: G protein involvement in a presynaptic mechanism. Neuron 13 : 1447 1455.
89. Rasmussen EB, Huskinson SL 2008) Effects of rimonabant on behavior maintained by progressive ratio schedules of sucrose reinforcement in obese Zucker (fa/fa) rats. Behav Pharmacol 19 : 735 742.
90. Rice ASC, Farquhar-Smith WP, Nagy I 2002) Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 66 : 243 256. (Pubitemid 34743599)
91. Richardson JD, Aanonsen L, Hargreaves KM 1997) SR 141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur J Pharmacol 319 : R3 R4.
92. Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G 1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350 : 240 244. (Pubitemid 24268029)
93. Ryberg E, Larsson N, Sjogren S, Hjorth S, Hermansson NO, Leonova J, Elebring T, Nilsson K, Drmota T, Greasley PJ 2007) The orphan receptor GPR55 is a novel cannabinoid receptor. Br J Pharmacol 152 : 1092 1101. (Pubitemid 350166046)
94. Santhakumar V, Ratzliff AD, Jeng J, Toth Z, Soltesz I 2001) Long-term hyperexcitability in the hippocampus after experimental head trauma. Ann Neurol 50 : 708 717. (Pubitemid 33116130)
95. Schmidt D, Loscher W 2005) Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Epilepsia 46 : 858 877. (Pubitemid 40847354)
96. Schuchmann S, Schmitz D, Rivera C, Vanhatalo S, Salmen B, Mackie K, Sipila ST, Voipio J, Kaila K 2006) Experimental febrile seizures are precipitated by a hyperthermia-induced respiratory alkalosis. Nat Med 12 : 817 823. (Pubitemid 44050072)
97. Shohami E, Novikov M, Mechoulam R 1993) A nonpsychotropic cannabinoid, HU-211, has cerebroprotective effects after closed head injury in the rat. J Neurotrauma 10 : 109 119. (Pubitemid 23209478)
98. Shouman B, Fontaine RH, Baud O, Schwendimann L, Keller M, Spedding M, Lelievre V, Gressens P 2006) Endocannabinoids potently protect the newborn brain against AMPA-kainate receptor-mediated excitotoxic damage. Br J Pharmacol 148 : 442 451. (Pubitemid 43882080)
99. Sills GJ 2007) Seizures beget seizures: a lack of experimental evidence and clinical relevance fails to dampen enthusiasm. Epilepsy Curr 7 : 103 104.
100. Straiker A, Mackie K 2007) Metabotropic suppression of excitation in murine autaptic hippocampal neurons. J Physiol 578 : 773 785. (Pubitemid 46165509)
101. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, Yamashita A, Waku K 1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215 : 89 97.
102. Temkin NR 2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42 : 515 524. (Pubitemid 32322197)
103. Terranova JP, Storme JJ, Lafon N, Perio A, Rinaldi-Carmona M, Le Fur G, Soubrie P 1996) Improvement of memory in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology (Berl) 126 : 165 172. (Pubitemid 26246767)
104. Varma N, Carlson GC, Ledent C, Alger BE 2001) Metabotropic glutamate receptors drive the endocannabinoid system in hippocampus. J Neurosci 21 : RC188.
105. Wallace MJ, Martin BR, DeLorenzo RJ 2002) Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur J Pharmacol 452 : 295 301. (Pubitemid 35279432)
106. Wallace MJ, Blair RE, Falenski KW, Martin BR, DeLorenzo RJ 2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307 : 129 137. (Pubitemid 37151898)